Total Renal Care Names George B. DeHuff III President and Chief Operating Officer
 TORRANCE, Calif., May 11 /PRNewswire/ -- Total Renal Care Holdings, Inc.
(NYSE: TRL) today announced the appointment of George B. DeHuff III, 45, to
the newly created position of President and Chief Operating Officer.  Victor
M.G. Chaltiel will continue as Chairman of the Board and Chief Executive
Officer. Mr. DeHuff joins TRL on May 17, 1999 and will be responsible for the
day-to-day operations of the Company, reporting directly to Mr. Chaltiel.
    Barry C. Cosgrove, Senior VP, General Counsel and Secretary, John E. King,
Senior VP and Chief Financial Officer and Stan M. Lindenfeld, MD, Senior VP
and Chief Medical Officer are joining Mr. DeHuff to constitute a newly
organized Office of the Chairman to work directly with Mr. Chaltiel to
facilitate the long term growth and success of the company.
    "DeHuff has proven his ability to successfully lead large healthcare
service organizations," Chaltiel said.  "Acquiring an executive of his caliber
and knowledge underscores our potential and will strengthen our position
domestically and internationally."
    DeHuff has more than 20 years of executive management experience.  From
1994 to early 1999, he served in a variety of positions, including Chief
Operating Officer as well as President and Chief Executive Officer, with
American Medical Response (AMR), the nation's largest ambulance and medical
transportation provider with more than 20,000 employees. AMR is now a
subsidiary of Laidlaw, Inc.
    From 1991 to 1994, he was President and Chief Operating Officer of
LifeFleet, Inc., also an ambulance and medical transportation provider, before
its sale to a third party.  Earlier he was President and Chief Executive
Officer of EECO Inc., a then publicly traded manufacturing organization, and
previously held executive positions with Price Waterhouse and HI-TEK
    DeHuff earned a Master of Business Administration degree from the
University of Michigan in 1977 and a Bachelor of Arts degree in economics from
Oakland University, Rochester, Mich., in 1975.  Mr. DeHuff lives with his
wife, Karen, and their four children in Southern California, and was selected
following a nationwide search by LAI Worldwide, executive recruiters and

    Torrance, California-based Total Renal Care Holdings, Inc. is the second
largest (and largest independent) worldwide provider of integrated dialysis
services for patients suffering from chronic kidney failure.  The Company owns
and operates high-quality, free-standing kidney dialysis centers and home
peritoneal dialysis programs in 35 states, as well as Washington, D.C., Puerto
Rico, Guam, Argentina and several European countries.  It also provides high
quality acute hemodialysis services to inpatients at approximately
320 hospitals.  As of May 1, 1999, TRL operated 552 outpatient dialysis
facilities serving more than 43,000 patients, including more than
3,000 patients in 37 centers under TRL management.  TRL also operates ESRD
laboratory and pharmacy facilities, as well as vascular access management,
transplant services and ESRD clinical research programs.

    This release contains forward-looking statements which are made pursuant
to the safe harbor provisions of the Private Securities Litigation Reform Act
of 1995.  These forward-looking statements include statements regarding
potential strengthening of operations and market opportunities and involve
risks and uncertainties that could cause actual results to differ materially
from the forward-looking statements.  Factors which could cause or contribute
to such differences include, but are not limited to, the uncertainties
associated with governmental regulation, general economic and other market
conditions, and the "risk factors" set forth in the Company's filings with the
Securities and Exchange Commission.  The forward-looking statements should be
considered in light of these risks and uncertainties.

SOURCE  Total Renal Care Holdings, Inc.